Cook Medical Technologies LLC

Cook Incorporated

Med Institute Incorporated

William Cook Australia Pty. Ltd.

David Paul Biggs

Sean Chambers

Scott E Eells

Shyam S V Kuppurathanam

David Ernest Hartley

Krasnodar Ivancev

Anthony O Ragheb

David Douglas Grewe

Patrick H Ruane

Shyam Kuppurathanam

Peter Harris

Jessica A Schafersman

Shaym Sv Kuppurathanam

An implantable graft device having treated yarn is disclosed. The device comprises a graft body forming a lumen defining a longitudinal axis and comprising proximal and distal ends. The graft body comprises a woven fabric having warp yarns aligned in a first direction and a weft yarns aligned in a second direction. At least one of the weft yarns and the warp yarns has an agent applied thereto defining treated yarns of the graft body.

Implantable graft device having treated yarn and method for making same

The disclosure relates to an implantable woven graft for bridging a defect in a main vessel near one or more branch vessels. The graft includes a region of reduced density. Reduced density regions are alignable with at least one of the one or more branch vessels, and are suitable for in situ fenestration, for example by perforation. The disclosed examples are particularly suited for bridging abdominal aortic aneurysms.

Variable weave graft with metal strand reinforcement for in situ fenestration

An implantable graft device having treated yarn is disclosed. The device includes a graft body forming a lumen defining a longitudinal axis and having proximal and distal ends. The graft body is constructed from a woven fabric having warp yarns aligned in a first direction and a weft yarns aligned in a second direction. At least one of the weft yarns and the warp yarns has an agent applied thereto defining treated yarns of the graft body.

This invention relates to medical devices and an angiotensin II type 2 (AT) receptor antagonist compound, the medical device being adapted to release the ATreceptor antagonist compound within a body of a patient. This invention also relates to medical devices and methods of treatment of disease, such as aneurysms and aortic dissection. Medical devices may include coated stents, grafts, stent grafts, balloons and catheters.

Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists

An introducer assembly for accessing a target site in the anatomy of a patient includes a sheath having a proximal end and a distal end, and having a lumen extending therethrough. At least a portion of the sheath distal end has a curved configuration. A tapered dilator has a proximal end and a distal end, and is sized to be received in the sheath lumen. The dilator has a length such that at least a distal tip portion of the dilator extends beyond the distal end of the sheath when the dilator is received in the sheath lumen. The dilator may be formed of polyurethane, and has a stiffness not exceeding a stiffness of the sheath curved portion such that the sheath substantially maintains the curved configuration when the dilator is received in the sheath lumen.

High flex introducer assembly

Growing community of inventors

Bloomington, IN, United States of America

David Paul Biggs